Altimmune Inc (NASDAQ:ALT)
| 25.18 BATS BZX Real-Time Price As of 1:11pm ET |  +2.86 / +12.81%Today’s Change | 1.51 Today|||52-Week Range 27.82 | +1,232.28% Year-to-Date |
Latest ALT News | Press Releases
| Why Altimmune Shares Are Flying High Today 12:12pm / MotleyFool.com - Paid Partner Content | Here's the Surprising Coronavirus Stock You'll Really Want to Own Jul 07 / MotleyFool.com - Paid Partner Content |
| Better Coronavirus Stock: Altimmune vs. Vaxart Jul 08 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 22.32 |
| Today’s open | 27.59 |
| Day’s range | 24.70 - 27.82 |
| Volume | 267,830 |
| Average volume (3 months) | 3,560,015 |
| Market cap | $449.5M |
Data as of 1:11pm ET, 07/13/2020
Growth & Valuation
| Earnings growth (last year) | +89.46% |
| Earnings growth (this year) | -13.12% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -43.85% |
| P/E ratio | NM |
| Price/Sales | 4.28 |
| Price/Book | 7.52 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PRTAProthena Corporation... | +0.39 | +3.43% |
| MGTXMeiraGTx Holdings PL... | -0.02 | -0.16% |
| SIGASIGA Technologies In... | +0.08 | +1.40% |
| XBITXBiotech Inc | +0.10 | +0.68% |
Data as of 1:06pm ET, 07/13/2020
Financials
| Next reporting date | August 18, 2020 |
| EPS forecast (this quarter) | -$0.52 |
| Annual revenue (last year) | $5.8M |
| Annual profit (last year) | -$20.5M |
| Net profit margin | -353.71% |
Profile
Sector Commercial Services |
Industry Miscellaneous Commercial Services |
No executives to display |
Corporate headquarters Gaithersburg, Maryland |
Forecasts
